Pharming (PHAR) Net Margin (2020 - 2026)

Pharming (PHAR) posted Net Margin of 7.2% for Q1 2026, down 244.59% on a QoQ basis from 4.98% in Q4 2025, and up 1860949542.0% year-over-year from N/an in Q1 2025.

Pharming (PHAR) Net Margin (2020 - 2026) Analysis & Trends

Pharming's Net Margin history runs 7 years deep, the most recent figure standing at 7.2% for Q1 2026.

  • Quarterly Net Margin rose 1860949542.0% year-over-year to 7.2% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.98% (up 2204.0% YoY) and the FY2025 annual result came in at 0.76%, up 474.0% from the prior year.
  • Net Margin was 7.2% for Q1 2026 at Pharming, down from 4.98% in the prior quarter.
  • Across five years, Net Margin topped out at 31.34% in Q2 2022 and bottomed at 22394128.02% in Q1 2024.
  • A 5-year average of 3094803.33% and a median of 1.47% in 2024 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2024 — Net Margin tumbled 2000000000 bps — and 2026, when it surged 1860949542 bps.
  • Pharming's Net Margin stood at 18.74% in 2022, then plunged by 149 bps to 9.11% in 2023, then tumbled by 63535828 bps to 5790220.05% in 2024, then soared by 100 bps to 4.98% in 2025, then sank by 245 bps to 7.2% in 2026.
  • Business Quant data shows PHAR's Net Margin at 7.2% in Q1 2026, 4.98% in Q4 2025, and 0.0% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Pharming 9.02 Bn 8.96 Bn 65.80 Mn -7.20%

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.20%
Dec 31, 2025 4.98%
Sep 30, 2025 0.00%
Jun 30, 2025 -5,817,833.62%
Mar 31, 2025 -18,609,502.62%
Dec 31, 2024 -5,790,220.05%
Sep 30, 2024 -1.47%
Jun 30, 2024 -10.54%
Mar 31, 2024 -22,394,128.02%
Dec 31, 2023 -9.11%
Sep 30, 2023 5.20%
Jun 30, 2023 0.00%
Mar 31, 2023 -28.70%
Dec 31, 2022 18.74%
Sep 30, 2022 16.79%
Jun 30, 2022 31.34%
Mar 31, 2022 7.73%
Dec 31, 2021 -10.90%
Sep 30, 2021 -33.83%
Jun 30, 2021 24.63%